Renalytix Statistics
Total Valuation
Renalytix has a market cap or net worth of 48.47 million. The enterprise value is 55.15 million.
| Market Cap | 48.47M |
| Enterprise Value | 55.15M |
Important Dates
The next estimated earnings date is Tuesday, February 18, 2025.
| Earnings Date | Feb 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +27.19% |
| Shares Change (QoQ) | -23.50% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 173.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.97 |
| EV / Sales | 25.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.26 |
Financial Position
The company has a current ratio of 0.24
| Current Ratio | 0.24 |
| Quick Ratio | 0.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.34 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -123.74% |
| Return on Capital (ROIC) | -501.75% |
| Revenue Per Employee | 23,059 |
| Profits Per Employee | -274,804 |
| Employee Count | 102 |
| Asset Turnover | 0.19 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.18 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 73.49 |
| Average Volume (20 Days) | 84,147 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Renalytix had revenue of 2.35 million and -28.03 million in losses. Loss per share was -0.25.
| Revenue | 2.35M |
| Gross Profit | 299,000 |
| Operating Income | -24.09M |
| Pretax Income | -28.02M |
| Net Income | -28.03M |
| EBITDA | -23.89M |
| EBIT | -24.09M |
| Loss Per Share | -0.25 |
Balance Sheet
The company has 909,000 in cash and 8.25 million in debt, giving a net cash position of -7.34 million.
| Cash & Cash Equivalents | 909,000 |
| Total Debt | 8.25M |
| Net Cash | -7.34M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -11.32M |
| Book Value Per Share | -0.07 |
| Working Capital | -9.13M |
Cash Flow
In the last 12 months, operating cash flow was -24.44 million and capital expenditures -4,000, giving a free cash flow of -24.45 million.
| Operating Cash Flow | -24.44M |
| Capital Expenditures | -4,000 |
| Free Cash Flow | -24.45M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 12.71% |
| Operating Margin | -1,024.15% |
| Pretax Margin | -1,191.50% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Renalytix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.19% |
| Shareholder Yield | -27.19% |
| Earnings Yield | -97.39% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Renalytix has an Altman Z-Score of -80.33. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -80.33 |
| Piotroski F-Score | n/a |